ArticleArchives of pharmacal research2026
eHsp90α enhances breast cancer cell invasion by activating the LRP1-EGFR/AKT-twist/snail signaling axis in cancer-associated fibroblasts.
Article in Archives of pharmacal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Extracellular heat shock protein 90 alpha (eHsp90α) has been implicated in promoting cancer cell invasion and metastasis. However, the role of eHsp90α in the tumor microenvironment remains poorly understood. In the present study, we provide the first evidence that eHsp90α aggravates the invasiveness of cancer-associated fibroblasts (CAFs) through low-density lipoprotein receptor-related protein 1 (LRP1) and consequent upregulation of epithelial-mesenchymal transition (EMT)-associated transcription factor expression. We observed that eHsp90α induces CAFs invasiveness. However, silencing of Twist, Snail and Slug expressions significantly attenuated eHsp90α-induced CAFs invasiveness. In addition, transfecting CAFs with LRP1 short interfering RNA (siRNA) markedly inhibited eHsp90α-induced CAFs invasion and EMT-associated transcription factor expression. Intriguingly, we observed that the epidermal growth factor receptor (EGFR)/AKT signaling is located downstream of LRP1 and governs eHsp90α-induced Twist and Snail but not Slug expression required for CAFs invasion. Moreover, we demonstrated that these EMT-associated transcription factors of CAFs are indispensable for breast cancer cell invasion. Collectively, the present data reveal that eHsp90α increases CAFs invasiveness through LRP1 and subsequent EMT-associated transcription factor expression to promote breast cancer invasion, presenting potential therapeutic targets to impede breast cancer progression.
Indexed as
Identifiers
42315823What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.